Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Qumaruzaman"'
Autor:
Qumaruzaman, M. Beshtawi, B. Mohammed, S. Mahmood Alam, Ruwayda Dham, Nasir Idkaidek, Isra' Admour, Naji M. Najib
Publikováno v:
Biopharmaceutics & Drug Disposition. 26:243-247
A bioequivalence study of two oral formulations of 20 mg fluoxetine was carried out in 24 healthy volunteers following a single dose, two-sequence, crossover randomized design at International Pharmaceutical Research Centre (IPRC), Amman, Jordan. The
Autor:
Qumaruzaman, S. Mahmood Alam, Ayman Adel, Naji M. Najib, Ruwayda Dham, B. Mohammed, Nasir Idkaidek, Isra' Admour, Sahar Al-Masri
Publikováno v:
Biopharmaceutics & Drug Disposition. 26:1-5
A bioequivalence study of two oral formulations of 100 mg atenolol was carried out in 24 healthy volunteers following a single dose, two-sequence, cross-over randomized design at the International Pharmaceutical Research Centre (IPRC), as a joint ven
Autor:
Isra' Admour, Ruwayda Dham, Qumaruzaman, Rafel E. B. Astigarraga, S. Mahmood Alam, Gliberto De Nucci, Naji M. Najib, Ayman Adel, Nasir Idkaidek
Publikováno v:
Biopharmaceutics & Drug Disposition. 24:315-320
The bioequivalence of two brands of enalapril 20 mg tablets was demonstrated in 24 healthy human volunteers after a single oral dose in a randomized cross-over study, conducted at IPRC, Amman, Jordan. Reference (Renitec, MSD, Netherlands) and test (N
Autor:
Qumaruzaman, Ayman Adel, Ruwayda Dham, Naji M. Najib, Gliberto De Nucci, Isra' Admour, S. Mahmood Alam, Rafel E. B. Astigarraga, Nasir Idkaidek
Publikováno v:
Biopharmaceutics & Drug Disposition. 24:183-189
The pharmacokinetics of two brands of simvastatin 40 mg tablets were compared in 24 healthy human volunteers after a single oral dose in a randomized cross-over study, conducted at IPRC, Amman, Jordan. Reference (Zocor, MSD, Netherlands) and test (Si
Autor:
Khalil I. Al-Khamis, Tawfeeq A Al-Najjar, Khalid A. Al-Rashood, Esmail M. Niazy, Mohd A. Al-yamani, Mansour S. Alsaid, Y. M. El-Sayed, Ruwayda Dham, Q Zaman Qumaruzaman, Sulaiman Al-Bella, Syed M. Alam
Publikováno v:
Biopharmaceutics & Drug Disposition. 21:205-210
A bioequivalence study of two oral formulations of 500 mg cefuroxime axetil was carried out in 24 healthy volunteers following a single dose, standard two-treatment cross-over design at the College of Pharmacy, King Saud University, Riyadh, Saudi Ara
Autor:
Ruwayda Dham, Naji M. Najib, Qumaruzaman, S. Mahmood Alam, Nasir Idkaidek, M. Beshtawi, Isra' Admour, B. Mohammed
Publikováno v:
Biopharmaceuticsdrug disposition. 26(1)
Two studies were performed to assess the relative bioavailability of Lovrak (Julphar, UAE) compared with Zovirax (Glaxo Wellcome, UK) at the International Pharmaceutical Research Center (IPRC), Amman, Jordan. One study involved acyclovir tablets and
Autor:
Ruwayda Dham, Ayman Adel, Nasir Idkaidek, Naji M. Najib, Qumaruzaman, Isra' Admour, S. Mahmood Alam, B. Mohammed, Sahar Al-Masri
Publikováno v:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 55(1)
A study was conducted to establish bioequivalence between two oral cyclosporine 100 mg capsules, Sigmasporin Microoral (Gulf Pharmaceutical Industries - Julphar, United Arab Emirates, under technical co-operation with Sigma Pharma, Brazil) and Sandim
Autor:
M S, Al-Said, K I, Al-Khamis, E M, Niazy, Y M, El-Sayed, K A, Al-Rashood, S, Al-Bella, M A, Al-Yamani, T A, Al-Najjar, S M, Alam, R, Dham, Q, Zaman Qumaruzaman
Publikováno v:
Biopharmaceuticsdrug disposition. 21(6)
A bioequivalence study of two oral formulations of 500 mg cefuroxime axetil was carried out in 24 healthy volunteers following a single dose, standard two-treatment cross-over design at the College of Pharmacy, King Saud University, Riyadh, Saudi Ara
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.